Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis

Clinical trial NCT07059130 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07059130
Sponsor: Rubix LS
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease (CD)Crohns Disease Ulcerative Colitis (UC)

Start date: 2025-07-16
Primary completion: 2026-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.